[EN] DERIVATIVES OF 3-HETEROARYLISOXAZOL-5-CARBOXYLIC AMIDE USEFUL FOR THE TREATMENT OF INTER ALIA CYSTIC FIBROSIS<br/>[FR] DÉRIVÉS DE 3-HÉTÉROARYLISOXAZOL-5-AMIDE CARBOXYLIQUE UTILES DANS LE TRAITEMENT, ENTRE AUTRES, D'UNE FIBROSE KYSTIQUE
                        
                            
                                申请人:PROTEOSTASIS THERAPEUTICS INC
                            
                            
                                公开号:WO2016105468A1
                            
                            
                                公开(公告)日:2016-06-30
                            
                            The present disclosure is based, in part, on the discovery that disclosed compounds can increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.
                            本公开涉及的部分基于发现,所披露的化合物可以增加在人类支气管上皮细胞(hBE)中测量的囊性纤维化跨膜传导调节蛋白(CFTR)的活性。